Purification of proteins

Patent metadata

Field	Value
Publication number	US-10233211-B2
Application number	US-201313955024-A
Country	US
Kind code	B2
Filing date	Jul 31, 2013
Priority date	Dec 21, 2006
Publication date	Mar 19, 2019
Grant date	Mar 19, 2019

Abstract

The present invention relates to a selectively soluble polymer capable of binding to a desired molecules in an unclarified mixture containing various biological materials and the methods of using such a polymer to purify a molecule from such a mixture. The polymer is soluble in the mixture under a certain set of process conditions such as pH or temperature and/or salt concentration and is rendered insoluble and precipitates out of solution upon a change in the process conditions. The polymer is capable of binding to the desired molecule (protein, polypeptide, etc) and remains capable of binding to that molecule even after the polymer is precipitated out of solution. The precipitate can then be filtered out from the remainder of the stream and the desired biomolecule is recovered such as by elution and further processed.

First claim

What is claimed:

1. A method for purifying IgG antibody from an unclarified mixture containing impurities comprising:
a. providing the mixture at a set of conditions,
b. adding one or more polymers, soluble in said mixture under the set of conditions and capable of reversibly and selectively binding to at least the IgG antibody, said one or more polymers being one or more polyvinyl pyridine-containing polymers;
c. mixing the one or more solubilized polymers throughout the mixture;
d. precipitating the one or more polymers and at least the bound IgG antibody out of solution by changing the set of conditions in the mixture; and
e. separating the precipitated polymer and at least the bound IgG antibody from the mixture.

2. The method of claim 1 wherein the one or more polymers are precipitated by a change in pH.

3. The method of claim 1 wherein the one or more polymers are solubilized and precipitated by a change in pH.

Assignees

• Emd Millipore Corp

Inventors

• Moya Wilson
• Jaber Jad

Classifications

• C07K1/32 Primary

  as complexes · CPC title

• A61P43/00

  Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

• C07K1/30

  by precipitation · CPC title